Biotalys: CEO and Two Executives Depart the Company
Biotalys announces several changes within its governance bodies. The board of directors is reduced from eight to six members and the executive committee from four to two members.
Immediate Departures in Leadership
Laura Meyer, a board member and chair of the audit committee since September 2024, leaves her position with immediate effect. Kevin Helash, CEO since October 2023, also departs the company with immediate effect. Kamal El Mernissi, director of business development since October 2024, will leave the company effective March 31, 2026.
Interim and New Appointments
Carlo Boutton, currently the chief scientific officer, will assume the role of interim CEO. Patrik Haesen has been appointed by the board to take over as chair of the audit committee.